4月30日 - ** Regulus Therapeutics RGLS.O股价盘前翻了一番多，达到7.79美元
** 诺华公司提出以每小时 7 美元的预付现金收购 (link) Regulus，并在肾病药物法拉布森达到某些监管里程碑时再支付每小时 7 美元的预付现金。
** 预付价格为 8 亿美元
** 截至上次收盘，RGLS 的股价今年已经上涨了一倍多
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.